Literature DB >> 21153105

Preferential accumulation in vivo of 24R,25-dihydroxyvitamin D(3) in growth plate cartilage of rats.

E G Seo1, Z Schwartz, D D Dean, A W Norman, B D Boyan.   

Abstract

Vitamin D(3) is metabolized in vivo through 25-(OH)D(3) (25D) to both 1α,25-(OH)(2)D(3) (1,25D) and 24R,25-(OH)(2)D(3) (24,25D). Whereas it is assumed that this metabolism occurs primarily in the kidney, recent studies show that there are extrarenal 1α-and 24R-hydroxylase activities as well, and in chondrocytes, these enzymes are regulated by hormones and growth factors. Furthermore, chondrocytes from the resting zone of growth plate cartilage are a target cell population for 24,25D action, suggesting that this vitamin D metabolite may be targeted to this tissue in vivo. To test this hypothesis, 30 normal male Sprague Dawley rats (120 ±20 g) were divided into three groups of eight animals each, and a control group of six animals, and fed ad libitum for 2 wk, a standard rat chow (Teklad LM-485), which contained 3 IU vitamin D(3)/g. The rats were then injected im daily at 9:00AM: , for 4 consecutive d, with 0.1 mL of either [(3)H]-25D, [(3)H]-1,25D or [(3)H]-24,25D. Each dose contained 13 pmol of hormone (0.36 μCi/dose). The distribution of these metabolites was assessed in tibial bone (B) following ablation of the bone marrow, articular cartilage from the tibia (AC), costochondral growth plate cartilage (GC), serum (S), small intestine (I), and kidney (K). The use of high specific activity tritiated vitamin D metabolites facilitated determining tissue localization and further metabolism without perturbation of the body pools of each major metabolite. Accumulation of [(3)H]-1,25D or [(3)H]-24,25D in each tissue was compared to circulating serum levels. In rats dosed with [(3)H]-25D, the tissue:serum ratios for 1,25D were 4.1 (AC), 35.4 (GC), 1.3 (B), 0.7 (K), and 3.0 (I); and tissue:serum ratios for 24,25D were 1.6 (AC), 9.9 (GC), 0.04 (B), 0.2 (K), and 0.4 (I). In rats dosed with [(3)H]-24,25D alone, GC was the only tissue to accumulate the administered metabolite at a concentration significantly higher than that of serum. Similarly, in rats dosed with [(3)H]-1,25D alone, GC was the only tissue to accumulate 1,25D at a concentration higher than that of serum. These results demonstrate, for the first time, that under in vivo conditions, GC specifically accumulates 24,25D and 1,25D. This suggests that growth plate may be a target organ for these two hormones.

Entities:  

Year:  1996        PMID: 21153105     DOI: 10.1007/BF02738700

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Serum concentration of 24, 25-dihydroxyvitamin D in normal children and in children with rickets.

Authors:  T M Nguyen; H Guillozo; M Garabedian; E Mallet; S Balsan
Journal:  Pediatr Res       Date:  1979-09       Impact factor: 3.756

2.  24, 25-dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation.

Authors:  A Ornoy; D Goodwin; D Noff; S Edelstein
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

3.  Specific binding of 24R,25-dihydroxyvitamin D3 to chick intestinal mucosa: 24R,25-dihydroxyvitamin D3 is an allosteric effector of 1,25-dihydroxyvitamin D3 binding.

Authors:  F Wilhelm; F P Ross; A W Norman
Journal:  Arch Biochem Biophys       Date:  1986-08-15       Impact factor: 4.013

4.  A possible role of vitamin D receptors in regulating vitamin D activation in the kidney.

Authors:  K Iida; T Shinki; A Yamaguchi; H F DeLuca; K Kurokawa; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 5.  Vitamin D: metabolism and biological actions.

Authors:  H L Henry; A W Norman
Journal:  Annu Rev Nutr       Date:  1984       Impact factor: 11.848

6.  Reduced mechanical competence of bone by ovariectomy and its preservation with 24R,25-dihydroxyvitamin D3 administration in beagles.

Authors:  M Yamaura; T Nakamura; Y Nagai; A Yoshihara; K Suzuki
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

7.  Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro.

Authors:  C Rudberg; G Akerström; H Johansson; S Ljunghall; J Malmaeus; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1984-03

8.  Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone.

Authors:  H H Malluche; H Henry; W Meyer-Sabellak; D Sherman; S G Massry; A W Norman
Journal:  Am J Physiol       Date:  1980-05

9.  Healing of rachitic lesions in chicks by 24R,25-dihydroxycholecalciferol administered locally into bone.

Authors:  C Lidor; I Atkin; A Ornoy; S Dekel; S Edelstein
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

10.  Localization of vitamin D3-responsive alkaline phosphatase in cultured chondrocytes.

Authors:  Z Schwartz; G Knight; L D Swain; B D Boyan
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

View more
  2 in total

1.  Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo.

Authors:  D D Dean; B D Boyan; Z Schwart; O E Muniz; M R Carreno; S Maeda; D S Howell
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats.

Authors:  Barbara D Boyan; Sharon L Hyzy; Qingfen Pan; Kayla M Scott; Richard D Coutts; Robert Healey; Zvi Schwartz
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.